Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Assessing Nutraceuticals for Hepatic Steatosis: A Standardized In Vitro Approach

Title: Assessing Nutraceuticals for Hepatic Steatosis: A Standardized In Vitro Approach
Authors: Victoria E. J. M. Palasantzas; Dicky Struik; Trijnie Bos; Sebo Withoff; Jingyuan Fu; Johan W. Jonker; Joanne A. Hoogerland
Source: Nutrients ; Volume 18 ; Issue 3 ; Pages: 388
Publisher Information: Multidisciplinary Digital Publishing Institute
Publication Year: 2026
Collection: MDPI Open Access Publishing
Subject Terms: MASLD; nutraceuticals; steatosis; intracellular triglycerides; HepG2; Fa2N-4; short-chain fatty acids; antioxidants; polyphenols; resmetirom
Subject Geographic: agris
Description: Background/Objectives: Nutraceuticals, including short-chain fatty acids (SCFAs) and antioxidants (AOXs), are nutrient-derived bioactive compounds considered as potential treatments for metabolic-associated steatotic liver disease (MASLD). However, in vitro studies of their effects are limited by inconsistent experimental conditions, including differences in cell lines, methods of steatosis induction, and culture media, and by reliance on qualitative rather than quantitative assessments. Here, we systematically evaluate the anti-steatotic potential of eight commonly used nutraceuticals—three SCFAs (butyrate, acetate, and propionate) and five AOXs (resveratrol, curcumin, berberine, chlorogenic acid, and vitamin E)—using a standardized in vitro approach. Methods: Following a systematic literature review to identify common experimental conditions, we developed an assay to validate steatosis induction and quantified the effects of the nutraceuticals. For our studies we used the HepG2 liver cancer cell line and the Fa2N-4 immortalized hepatocyte cell line. Steatosis was modeled by stimulating cells with free fatty acids and fructose for 48 h. Nutraceuticals were added either concurrently with steatotic stimulation, to assess preventive effects, or after 24 h to assess therapeutic effects. Anti-steatotic drugs (resmetirom, semaglutide, obeticholic acid, and a DGAT2 inhibitor) were included as positive controls. Intracellular triglyceride levels were measured to quantify steatosis. Results: A systematic review of 46 studies revealed large differences in culture conditions, steatosis induction, and nutraceutical assessment. In our experiments, most nutraceuticals did not reduce intracellular triglycerides, with the exception of vitamin E. Surprisingly, butyrate, berberine, and curcumin increased triglyceride accumulation. Resmetirom was the only drug that significantly decreased triglycerides, while obeticholic acid, semaglutide, and the DGAT2 inhibitor showed minimal or inconsistent effects. Fa2N-4 cells were generally ...
Document Type: text
File Description: application/pdf
Language: English
Relation: Nutrition and Public Health; https://dx.doi.org/10.3390/nu18030388
DOI: 10.3390/nu18030388
Availability: https://doi.org/10.3390/nu18030388
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.10DEF33F
Database: BASE